About Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted as a multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial to verify the efficacy and safety of high-dose methylcobalamin (mecobalamin) in patients with amyotrophic lateral sclerosis (ALS)
Conversely, accelerated telomere shortening has been associated with cardiovascular disease, diabetes, neurodegeneration, immune dysfunction, and all-cause mortality
If you planned 2ml, draw 2ml
It might also give you insights into whether the trial is enrolling healthy participants or if you must have the target diagnosis
Transport mechanism of GABA GABA undergoes transmembrane transport across both plasma and organelle membranes, encompassing intra- and intercellular movement, initially it was identified in animals in 1988 (Bormann, 1988) followed by plants in 1999 (Breitkreuz et al
The subcutaneous injection itself involves depositing medication into adipose tissue, which contains sensory nerve fibers